Results 91 to 100 of about 1,175 (172)

Safety and efficacy of two repeated cycles of ulipristal acetate in the management of symptomatic uterine fibroid among Indian women. [PDF]

Prz Menopauzalny, 2021
Jha S, Ahmed N, Sinha HH.
europepmc   +1 more source

Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids. [PDF]

J Clin Med, 2021
Szydłowska I, Grabowska M, Nawrocka-Rutkowska J, Kram A, Piasecka M, Starczewski A.   +5 more
europepmc   +1 more source

Dispensing and practice use patterns, facilitators and barriers for uptake of ulipristal acetate emergency contraception in British Columbia: a mixed-methods study. [PDF]

CMAJ Open, 2021
Chan MC, Munro S, Schummers L, Albert A, Mackenzie F, Soon JA, Ragsdale P, Fitzsimmons B, Renner R.   +8 more
europepmc   +1 more source

Use of IUDs for emergency contraception: current perspectives

Open Access Journal of Contraception, 2014
Rebecca McKay,1 Lynne Gilbert2 1Department of Obstetrics and Gynaecology, Peterborough City Hospital, Peterborough, Cambridgeshire, United Kingdom; 2Department of Contraception and Sexual Health, Cambridgeshire Community Services NHS Trust, Cambridge ...
McKay R, Gilbert L
doaj  

Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis. [PDF]

Drug Saf, 2020
Gatti M, Poluzzi E, De Ponti F, Raschi E.   +3 more
europepmc   +1 more source

Repeated intermittent ulipristal acetate in the treatment of uterine fibroids: a cost-effectiveness analysis

ClinicoEconomics and Outcomes Research, 2017
Kirk Geale,1,2 Ertan Saridogan,3 Matthieu Lehmann,4 Pablo Arriagada,4 Marcus Hultberg,2 Martin Henriksson5 1Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 2PAREXEL International, Stockholm, Sweden; 3Women ...
Geale K, Saridogan E, Lehmann M, Arriagada P, Hultberg M, Henriksson M   +5 more
doaj  

First report on electrochemical sensing of ulipristal acetate in pharmaceutical formulations and biological fluids using reduced graphene oxide-CuO nanohybrid based sensors. [PDF]

BMC Chem
Hameed YAS, Al-Bassam AZM, Azher OA, Alrashidi MA, Alanazi KD, Snari RM, Hameed AM, El-Metwaly NM.   +7 more
europepmc   +1 more source

Markers of Cellular Proliferation, Apoptosis, Estrogen/Progesterone Receptor Expression and Fibrosis in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids. [PDF]

J Clin Med, 2021
Szydłowska I, Grabowska M, Nawrocka-Rutkowska J, Piasecka M, Starczewski A.   +4 more
europepmc   +1 more source

Exploring Postpartum Use of Advance Provision of Ulipristal Acetate and Its Promotion of Reproductive Autonomy. [PDF]

O G Open
Lu CF, Serino M, Wegner L, Patterson L, Gurra M, Turner AM.   +5 more
europepmc   +1 more source

ULIPRISTAL ACETATE IN UTERINE FIBROIDS

Ulipristal Acetate as alternative to surgery in women with uterine ...
openaire   +1 more source